- Home
- / Colinz Laboratories
Colinz Laboratories
Stock Price
₹57.5
2024-10-29
Market Capitalization
₹260.5 M
2024-10-29
Revenue
₹61.4 M
FY, 2026
Colinz Laboratories Summary
Company Summary
- Overview
- Colinz Laboratories is a manufacturer of allopathic and Ayurvedic pharmaceutical products. It offers tablets, capsules, liquid orals, ointments, etc. The company caters to hypertension, diabetes, cholesterol, piles, and other ailments.
- Type
- Public
- Status
- Active
- Founded
- 1986
- Website
- http://www.findoc-cll.in
- Cybersecurity rating
Table of Contents
Colinz Laboratories Financials
Summary Financials
- Revenue (FY, 2026)
- ₹61.4M
- Gross profit (FY, 2026)
- ₹49.1M
- Net income (FY, 2026)
- ₹5.1M
- Cash (FY, 2026)
- ₹85.3M
- EBIT (FY, 2026)
- ₹7.4M
- Enterprise value
- $179.1M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026